OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The preclinical discovery and development of brexpiprazole for the treatment of major depressive disorder
Awais Aftab, Keming Gao
Expert Opinion on Drug Discovery (2017) Vol. 12, Iss. 10, pp. 1067-1081
Closed Access | Times Cited: 12
Awais Aftab, Keming Gao
Expert Opinion on Drug Discovery (2017) Vol. 12, Iss. 10, pp. 1067-1081
Closed Access | Times Cited: 12
Showing 12 citing articles:
Brexpiprazole—Pharmacologic Properties and Use in Schizophrenia and Mood Disorders
Marcin Siwek, Krzysztof Wojtasik-Bakalarz, Anna Julia Krupa, et al.
Brain Sciences (2023) Vol. 13, Iss. 3, pp. 397-397
Open Access | Times Cited: 20
Marcin Siwek, Krzysztof Wojtasik-Bakalarz, Anna Julia Krupa, et al.
Brain Sciences (2023) Vol. 13, Iss. 3, pp. 397-397
Open Access | Times Cited: 20
A simple route to 7-substituted Quinolin-2()-ones from -substituted anilines
Marisol Varela Ausec, M. A. PAYNE, J. Stewart, et al.
Results in Chemistry (2025), pp. 102089-102089
Open Access
Marisol Varela Ausec, M. A. PAYNE, J. Stewart, et al.
Results in Chemistry (2025), pp. 102089-102089
Open Access
Preclinical Evidence for the Use of Brexpiprazole + Antidepressant Treatment for Major Depressive Disorder and Post-Traumatic Stress Disorder: A Systematic Review
Malaak Brubaker, Sohum Kapadia, Vladimir Maletic, et al.
Neuropsychiatric Disease and Treatment (2025) Vol. Volume 21, pp. 421-436
Open Access
Malaak Brubaker, Sohum Kapadia, Vladimir Maletic, et al.
Neuropsychiatric Disease and Treatment (2025) Vol. Volume 21, pp. 421-436
Open Access
Brexpiprazole for treatment-resistant major depressive disorder
Michele Fornaro, Andrea Fusco, Annalisa Anastasia, et al.
Expert Opinion on Pharmacotherapy (2019) Vol. 20, Iss. 16, pp. 1925-1933
Closed Access | Times Cited: 31
Michele Fornaro, Andrea Fusco, Annalisa Anastasia, et al.
Expert Opinion on Pharmacotherapy (2019) Vol. 20, Iss. 16, pp. 1925-1933
Closed Access | Times Cited: 31
Efficacy and Safety of Antidiabetic Agents for Major Depressive Disorder and Bipolar Depression: A Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Trials
Jian Zhang, Rongyi Sun, Yang Cai, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 4, pp. 1172-1172
Open Access | Times Cited: 3
Jian Zhang, Rongyi Sun, Yang Cai, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 4, pp. 1172-1172
Open Access | Times Cited: 3
Recent Advances in representative small-molecule DRD2 inhibitors: Synthetic Routes and clinical applications
Yao Zhang, Jiangang Yu, Wen Wen
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116731-116731
Closed Access | Times Cited: 2
Yao Zhang, Jiangang Yu, Wen Wen
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116731-116731
Closed Access | Times Cited: 2
Comparative efficacy and safety of 4 atypical antipsychotics augmentation treatment for major depressive disorder in adults: A systematic review and network meta-analysis
Jia Wang, Wenwei Li, Mengting Li, et al.
Medicine (2023) Vol. 102, Iss. 38, pp. e34670-e34670
Open Access | Times Cited: 2
Jia Wang, Wenwei Li, Mengting Li, et al.
Medicine (2023) Vol. 102, Iss. 38, pp. e34670-e34670
Open Access | Times Cited: 2
Safety and Tolerability of Both Arm Ischemic Conditioning in Patients With Major Depression: A Proof of Concept Study
Zuowei Wang, Xujuan Li, Ningning Li, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 3
Zuowei Wang, Xujuan Li, Ningning Li, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 3
Quality of life among Iranian major depressive disorder patients: a qualitative study
Milad Rezaiye, Moloud Radfar, Masumeh Hemmati Maslakpak
Middle East Current Psychiatry (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 1
Milad Rezaiye, Moloud Radfar, Masumeh Hemmati Maslakpak
Middle East Current Psychiatry (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 1
Dopamine D 2 Partial Agonists – Discovery, Evolution, and Therapeutic Potential
Marlene A. Jacobson, Wayne E. Childers, Magid Abou‐Gharbia
(2019), pp. 83-130
Closed Access | Times Cited: 2
Marlene A. Jacobson, Wayne E. Childers, Magid Abou‐Gharbia
(2019), pp. 83-130
Closed Access | Times Cited: 2
Comparative efficacy and safety of 4 atypical antipsychotics augmentation treatment for major depressive disorder in adults: a systematic review and network meta-analysis
Jia Wang, Wen-Wei Li, Han-Biao Wu, et al.
Authorea (Authorea) (2023)
Open Access
Jia Wang, Wen-Wei Li, Han-Biao Wu, et al.
Authorea (Authorea) (2023)
Open Access
Combinación de antidepresivos vs. aumentación con antipsicóticos atípicos tras no lograr la remisión en la depresión unipolar
Rodolfo Philippi, Rodrigo Correa
Revista chilena de neuro-psiquiatría (2022) Vol. 60, Iss. 3, pp. 337-354
Open Access
Rodolfo Philippi, Rodrigo Correa
Revista chilena de neuro-psiquiatría (2022) Vol. 60, Iss. 3, pp. 337-354
Open Access
